Company intelligence / Profile preview

bioX

Salem, New Hampshire, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

bioX is a leader in process engineering, analytical methods, and feasibility consulting, with expertise spanning single-use technologies (SUT), cell and gene therapies, antibody manufacture, and bioprocess/analytical development. No direct clinical results; enables client programs in CGT, ERT, mAb, mRNA, microbiome, ADC, exosome, etc.

Modalities: Cell therapyGene therapyMonoclonal antibodyEnzyme replacement therapymRNA-based drugsSmall interfering RNAExosome-based therapyAntibody-drug conjugateATMPs (Advanced Therapy Medicinal Products)PolysaccharidePeptides (as analytical support)
Industry: Contract Manufacturing Organization

Partnerships

Partner to major biopharma/biotech companies for process engineering, quality consulting, and SUT deployment; specific names not disclosed

Beyond the preview

Go deeper on bioX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bioX.

Explore the full profile